Mariona A. Parera
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial.
Journal: Nature communications
Published: April 27, 2026
Airway organoids reveal patterns of influenza A tropism and adaptation in wildlife species.
Journal: Emerging microbes & infections
Published: April 17, 2026
Identification of Clinical and Genomic Features Associated with SARS-CoV-2 Reinfections.
Journal: Viruses
Published: May 11, 2025
Antimicrobial regime for gut microbiota depletion in experimental mice models.
Journal: Methods in cell biology
Published: January 25, 2025
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.
Journal: Vaccines
Published: September 05, 2023
Gut resistome linked to sexual preference and HIV infection.
Journal: BMC microbiology
Published: August 07, 2023
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Journal: The Journal of antimicrobial chemotherapy
Published: June 21, 2023
Probiotic effects on immunity and microbiome in HIV-1 discordant patients.
Journal: Frontiers in immunology
Published: October 10, 2022
Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota.
Journal: NPJ biofilms and microbiomes
Published: August 25, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North-Eastern Spain.
Journal: Transboundary and emerging diseases
Published: July 27, 2022
Last Updated: 09/26/2026